EJC Article – Results from a BTOG Trial

posted in: News | 0

Article from the European Journal of Cancer: Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial Please see article.

ASCO 2017 National Update

posted in: News | 0

ASCO 2017 National Update – Roy Castle Lung Cancer Foundation in partnership with BTOG Friday 9th June 2017 – Wellcome Collection, London The main focus for this Roy Castle Lung Castle Foundation meeting, planned in partnership with the British Thoracic … Read More

BTOG Position Statement December 2016

posted in: News | 0

The BTOG Position Statement 2016 is now available. This document provides the brief background of BTOG and achievements to date and confirms BTOG’s Core Principles and Key Activities. Please view here. 784018778_British Thoracic Oncology Group Position Statement Final Dec 2016  

About the BTOG Steering Committee Chair

posted in: News | 0

Dr Sanjay Popat is Consultant Thoracic Medical Oncologist at the Royal Marsden Hospital and Honorary Clinical Senior Lecturer in the Molecular Genetics and Genomics Group at the National Heart and Lung Institute, Imperial College London. Dr Popat has published in … Read More